TABLE 2.
Singletons | |||
---|---|---|---|
Peru | Rochester | Multiples | |
Maternal indicators, n | 43 | 20 | 5 |
Hb, g/dL | 11.92 ± 1.77 | 11.15 ± 1.18 | 11.64 ± 2.30 |
Anemic, % | 30 | 37 | 20 |
SF, μg/L | 32.49 [23.37, 45.17] | 19.47 [12.19, 23.54] | 27.50 [7.50, 100.93] |
<20 μg/L | 33 | 40 | 67 |
<12 μg/L | 17 | 22 | 33 |
sTfR, mg/L | 3.66 [2.98, 4.49] | 6.26 [5.01, 7.83] | 5.53 [0.61, 49.66] |
TBI, mg/kg | 3.39 ± 3.72 | 2.30 ± 3.03 | 2.89 ± 5.98 |
Hepcidin, ng/mL | — | 36.92 ± 58.20 [2.5, 207.1] | 9.59 ± 12.89 [1.2, 24.4] |
EPO, IU/L | — | 32.61 ± 23.00 [9.4, 109.5] | 44.7 ± 38.24 [10, 185.7] |
Folate, nmol/L | 12.42b [10.30, 14.97] | 37.40a [30.20, 46.32] | 20.32ab [8.83, 46.81] |
Deficient, % | 11 | 0 | 0 |
Vitamin B-12, pmol/L | 178.52 ± 81.57a | 262.21 ± 123.03b | 343 ± 101.06b |
Deficient, % | 37 | 21 | 0 |
Neonatal indicators, n | 42 | 20 | 11 |
Hb, g/dL | 15.71 ± 1.89a | 13.36 ± 3.05b | 15.37 ± 1.13a |
Anemic, % | 7a | 37b | 0a |
SF, μg/L | 167.84 ± 77.68 | 202.01 ± 115.97 | 148.46 ± 52.83 |
sTfR, mg/L | 6.23 ± 1.79 | 8.35 ± 2.15 | 7.68 ± 2.55 |
TBI, mg/kg | 10.18 ± 2.49 | 9.43 ± 2.80 | 9.10 ± 2.61 |
Hepcidin, ng/mL | — | 62.08 [8.5, 95.94] | 16.13 [9.58, 27.16] |
EPO, IU/L | — | 28.13 [17.07, 46.35] | 14.92 [10.42, 21.37] |
Folate, nmol/L | 24.36 ± 8.50b | 69.44 ± 26.61a | 85.59 ± 23.54a |
Deficient, % | 0 | 0 | 0 |
Vitamin B-12, pmol/L | 140.91b [110.72, 179.33] | 510.88a [348.05, 749.89] | 408.58a [298.94, 558.42] |
Deficient, % | 50b | 6a | 0a |
Values are means ± SDs or geometric means [95% CIs] unless otherwise indicated. Data were analyzed by ANOVA or chi-square test to assess indicator differences between cohorts measured with the same assay. Different superscript letters indicate significant differences between cohorts. EPO, erythropoietin; Hb, hemoglobin; SF, serum ferritin; sTfR, soluble transferrin receptor; TBI, total body iron.